Difference between revisions of "Central Nervous System - Metabolic Pathology"
Jump to navigation
Jump to search
m |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | + | {{toplink | |
| + | |backcolour = E0EEEE | ||
| + | |linkpage = Nervous System - Pathology | ||
| + | |linktext =Nervous System | ||
| + | |maplink = Nervous System (Content Map) - Pathology | ||
| + | |pagetype =Pathology | ||
| + | }} | ||
| + | <br> | ||
==Metabolic Disease== | ==Metabolic Disease== | ||
| Line 16: | Line 23: | ||
* Clinical signs are used in conjunction with biochemical studies of the affected organs or systems. | * Clinical signs are used in conjunction with biochemical studies of the affected organs or systems. | ||
| − | |||
| − | |||
| − | |||
Revision as of 11:07, 18 August 2008
|
Metabolic Disease
- Forebrain function may be altered by a variety of metabolic disturbances, including:
- Liver disease
- Renal disease
- Pancreatic disease
- Hypo/hyper-glycaemia
- Electrolyte abnormalities
- Acid-base abnormalities.
- Generally, the nervous system signs of these diseases are diffuse and often symmetrical in the rostrotentorial area.
- Strucural disease of the brain may result
- This may cause focal neurological deficits.
Diagnosis
- Clinical signs are used in conjunction with biochemical studies of the affected organs or systems.